Gary A. Ulaner, Ph.D.
Affiliations: | 2000 | Stanford University, Palo Alto, CA |
Area:
Molecular Biology, Cell BiologyGoogle:
"Gary Ulaner"Parents
Sign in to add mentorAndrew Hoffman | grad student | 2000 | Stanford | |
(Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Fardanesh R, Beavers K, Jochelson MS, et al. (2023) Value of subspecialist second opinion reads of 18F-FDG PET-CT examinations for patients with breast cancer. Nuclear Medicine Communications |
Cecil K, Huppert L, Mukhtar R, et al. (2023) Metabolic Positron Emission Tomography in Breast Cancer. Pet Clinics |
Ulaner GA, Muehlbauer S, Goldberg Z. (2020) Acute Aortic Dissection Initially Suspected on 18F-FDG PET/CT. Clinical Nuclear Medicine |
Ulaner GA, Carrasquillo JA, Riedl CC, et al. (2020) Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted Zr-Pertuzumab PET/CT. Radiology. 192828 |
Ulaner GA, Sobol NB, O'Donoghue JA, et al. (2020) CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging. Radiology. 192621 |
Ulaner GA, Landgren CO. (2020) Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders. Best Practice & Research. Clinical Haematology. 33: 101148 |
Ulaner GA. (2020) The QIBA Profile for FDG PET/CT: Improving the Value of PET. Radiology. 192409 |
Kirchner J, Riedl CC, Ulaner GA. (2019) Patient Repositioning Reveals a Malignant Pleura Effusion Initially Mistaken as a Bone Metastasis on 18FDG PET/CT. Clinical Nuclear Medicine. 44: 969-970 |
Ulaner GA, Saura C, Piha-Paul SA, et al. (2019) Impact of FDG PET Imaging for Expanding Patient Eligibility & Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Ulaner GA. (2019) PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact? Ajr. American Journal of Roentgenology. 1-12 |